Results 311 to 320 of about 1,321,964 (375)
Some of the next articles are maybe not open access.
[The progress of hepatitis C chronic infection in the immune mechanism].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2013丙型肝炎病毒(HCV)是肝硬化和肝癌的主要原因之一,目前全球超过1.7亿人感染HCV.在HCV感染的急性阶段,宿主调动起天然免疫和适应免疫系统以达到清除病毒的目的[1].但仍有约80％急性感染者最终会慢性化.很多因素参与急性丙型肝炎慢性化的过程,本文从天然免疫,细胞免疫以及病毒免疫逃逸性突变等在慢性化机制方面的研究进展综述如下.
Yan Ren, S. Zheng, Z. Duan
semanticscholar +1 more source
Current Treatment Options in Gastroenterology, 2001
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Tram T., Tran, Paul, Martin
openaire +2 more sources
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Tram T., Tran, Paul, Martin
openaire +2 more sources
, 2016 Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Athwal, Varinder, Prince, Martin
openaire +2 more sources
Annals of Internal Medicine, 2004
BACKGROUND Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.
S. Hadziyannis +13 more
semanticscholar +1 more source
BACKGROUND Treatment with pegylated interferon (peginterferon) and ribavirin for 48 weeks is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.
S. Hadziyannis +13 more
semanticscholar +1 more source
DMW - Deutsche Medizinische Wochenschrift, 2010
Chronic hepatitis C virus (HCV) infection is an important, global pathognomonic causal factor for development of liver cirrhosis and hepatocellular carcinoma. After parenteral transmission of the virus the majority of cases develop a chronic infection.
C Sarrazin, G Grammatikos
openaire +3 more sources
Chronic hepatitis C virus (HCV) infection is an important, global pathognomonic causal factor for development of liver cirrhosis and hepatocellular carcinoma. After parenteral transmission of the virus the majority of cases develop a chronic infection.
C Sarrazin, G Grammatikos
openaire +3 more sources
Southern Medical Journal, 1997
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +3 more sources
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +3 more sources
Management of Chronic Hepatitis C
Journal of the American Academy of Nurse Practitioners, 2001One purpose of the Clinical Practice Guideline column is to increase the awareness of the broad availability of existing guidelines and recommendations on various health topics. The hepatitis C virus (HCV) currently accounts for 20% to 40% of acute viral hepatitis, 60% to 80% of chronic hepatitis, and 20% to 30% of cirrhosis, end‐stage liver disease ...
Mary Jo Goolsby, James Blackwell
openaire +3 more sources
Treatment for chronic hepatitis C [PDF]
Current Gastroenterology Reports, 2003 Approximately four million Americans have been exposed to the hepatitis C virus (HCV) and are anti-HCV positive; almost three million are chronically infected and HCV RNA positive. Treatment for chronic hepatitis C has improved rapidly over the past 12 years from interferon monotherapy, with a sustained virologic response (SVR) rate of about 10% in the
openaire +2 more sources
THERAPY FOR CHRONIC HEPATITIS C
Gastroenterology Clinics of North America, 1994Hepatitis C is the silent epidemic of the 1970s and 1980s. Interferon alfa is currently the only effective treatment. Enthusiasm for interferon therapy must be tempered because advanced disease usually requires years or even decades to develop and does not occur in all patients.
Herbert L. Lim +2 more
openaire +3 more sources
Clinical Gastroenterology and Hepatology, 2005
The burden of chronic hepatitis C infection remains significant in the United States and worldwide. Increased knowledge regarding the natural history of acute and chronic infection and the key factors responsible for disease progression, risk for cirrhosis, and risk for hepatocellular carcinoma are critical in guiding secondary and tertiary prevention ...
Norah A. Terrault, Winnie Wong
openaire +3 more sources
The burden of chronic hepatitis C infection remains significant in the United States and worldwide. Increased knowledge regarding the natural history of acute and chronic infection and the key factors responsible for disease progression, risk for cirrhosis, and risk for hepatocellular carcinoma are critical in guiding secondary and tertiary prevention ...
Norah A. Terrault, Winnie Wong
openaire +3 more sources